The average P/S ratio for TXG's competitors is 8.94, providing a benchmark for relative valuation. 10X Genomics Inc Corp (TXG) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 9.84%, this premium appears unsustainable.